Oxidative stress contributes substantially to podocyte injury in diabetic kidney disease. The 46 mechanism of hyperglycemia-induced oxidative stress in podocytes is not fully understood.
Introduction

Elevation of G6PD expression decreased the apoptosis of podocyte 151
If high glucose or palmitate-induced decrease of G6PD protein plays a role in the survival of podocyte, 152 overexpression of G6PD should reverse the apoptosis. To test this, podocytes were transfected with 153 adenoviral G6PD vector (Ad-G6PD) to overexpress G6PD and apoptosis was examined. Empty 154 vector adenoviruses (Ad-null) were used as a control. As shown in Figure 5 , elevation of G6PD 155 protein significantly decreased podocyte apoptosis induced by either high-glucose ( Figure 5A ) or 156 palmitate ( Figure 5B ).
To investigate the mechanism underlying high glucose or palmitate-induced decrease in G6PD protein 172 level, we examined the G6PD mRNA level in podocytes under either high glucose or palmitate 173 incubation condition. Notably, palmitate significantly decreased G6PD mRNA level ( Figure 7A ), 174 while high glucose had no effect on it ( Figure 7B ). Furthermore, G6PD protein level was found to be 175 decreased in podocytes exposed to high glucose for 72 hours ( Figure 7C ). Thus, the reduction of 176 G6PD protein by high glucose was unlikely to be due to transcriptional regulation and might be 177 associated with the protein degradation. As the ubiquitin (Ub) proteasome pathway (UPP) degraded 178 the majority of intracellular proteins, we questioned whether this pathway was involved in decreasing 179 G6PD protein induced by high glucose. To this end, MG132, a proteasome inhibitor, was added， 180 which significantly rescued G6PD protein level in podocytes exposed to high glucose ( Figure 7D ). To 181 confirm the ubiquitylation of G6PD, Flag-tagged G6PD (Flag-G6PD) and His-tagged ubiquitin 182 (His-Ub) plasmids were constructed and validated in HEK293T cells ( Figure EV2A and EV2B).
183
Subsequently, Flag-G6PD and His-Ub constructs were co-transfected into HEK293T cells and 184 anti-Flag M2 beads were used for immunoprecipitation (IP). Western blot analysis using anti-His 185 antibody showed that G6PD was indeed ubiquitylated and the ubiquitylation was largely enhanced in 186 the presence of MG132 ( Figure 7E ). These results indicated that high glucose-induced G6PD protein 187 decrease depended on the ubiquitin proteasome pathway. 188 189 VHL ubiquitylated and degraded G6PD
190
The E3 ubiquitin ligases are the major enzymes responsible for recognizing and linking ubiquitin to 191 the target proteins. To identify the potential E3 ligase that ubiquitylated G6PD, we conducted yeast two hybrid (Y2H) screening [29] . Specifically, human G6PD was employed as the bait to screen 193 potential G6PD-interacting proteins from a Y2H prey library containing open reading frames from 194 human cDNAs encoding over 400 putative ubiquitin ligases or their substrate binding subunits. We 195 found that von Hippel-Lindau (VHL), a subunit of E3 ubiquitin ligase, interacted with G6PD in the 196 Y2H system ( Figure 8A ). A VHL plasmid was constructed with an HA tag (HA-VHL) and was 197 validated in HEK293T cells ( Figure EV2C ). The specific interaction between G6PD and VHL was 198 verified with co-immunoprecipitation (CO-IP) assay. As shown in Figure 8B , Flag-G6PD and 199 HA-VHL proteins formed a complex that survived the multistep procedures in CO-IP assay.
200
Collectively, the specific interaction between VHL and G6PD was verified in the yeast two hybrid 201 and CO-IP assay in cultured HEK293T cells, indicating that VHL was a G6PD-interacting protein.
202
To further examine whether VHL functioned as an E3 ubiquitin ligase against G6PD, the influence of 203 VHL on G6PD protein abundance was determined. As shown in Figure 8C , G6PD protein level 204 declined with the increased VHL protein expression. To further confirm the post-translational 205 regulation of VHL on G6PD, cycloheximide (CHX), an inhibitor of protein synthesis, was used. As 206 shown in Figure 8D , with the inhibition of protein synthesis by CHX, VHL also reduced G6PD 207 protein stability. To further ascertain the functional interaction of VHL with G6PD, ubiquitylation of 208 G6PD by VHL was explored under in vivo conditions. As shown in Figure 8E , G6PD was 209 conspicuously polyubiquitylated when HA-VHL was expressed along with His-Ub. Furthermore, we 210 assessed the effect of VHL knockdown on the G6PD protein. First, two siRNAs targeting to VHL 211 (siVHL#1 and siVHL#2) were constructed. HEK293T cells were transfected with scrambled siRNA 212 (scramble), siVHL#1 or siVHL#2 and G6PD protein level was analyzed. As shown in Figure 8F , endogenous VHL was silenced efficiently by siVHL#2. The knockdown of VHL concomitantly 214 resulted in the elevation of endogenous G6PD protein level ( Figure 8F ). These results suggested that 215 VHL functioned as an E3 ubiquitin ligase against G6PD. 216 217 K 366 and K 403 in G6PD were the major sites for VHL-mediated ubiquitylation 218 After an in vivo ubiquitylation reaction, ubiquitylated G6PD was enriched with anti-Flag M2 219 beads and subjected to tryptic digestion, followed by mass spectra (MS) analysis. The attachment of 220 ubiquitin to the side chain of a lysine (Lys) residue renders it resistant to trypsin cleavage, and tryptic 221 digestion of ubiquitin (chains) attached to the site leaves a -Gly-Gly-group, originating from the C 222 terminus of ubiquitin, on the side chain of the modified Lys [30] . Based on these signature features, 223 ubiquitylation sites in G6PD were identified from tandem mass spectrometry (MS/MS) spectra.
224
Altogether, we found that a total of 5 Lys residues (K 97 , K 366 , K 403 , K 407 and K 408 ) were ubiquitylated 225 by VHL ( Figure 9A ).
226
To examine which lysine residue(s) may be the main ubiquitylation sites, we generated G6PD mutants 227 bearing single or double lysine-to-arginine (Lys-to-Arg) substitutions and polyubiquitylated G6PD 228 was assessed. As shown in Figure 9B and 9C, compared with wild-type G6PD, Ub conjugation to 229 G6PD mutants with either Lys366-to-Arg (K 366R ) substitution or Lys403-to-Arg (K 403R ) substitution 230 was largely reduced. However, the ubiquitylation of the other G6PD mutants (K 97R , K 407R and K 408R ) 231 was not significantly affected. Remarkably, Lys-to-Arg substitutions on both K 366 and K 403 sites 232 (K 366+403R ) almost completely abolished the VHL-mediated ubiquitylation on G6PD ( Figure 9C ).
Discussion
235
The current study reveals the biochemical mechanism that high glucose promotes the degradation of 236 G6PD protein through the ubiquitin proteasome pathway, which leads to podocyte injury. Further, 237 VHL, an E3 enzyme subunit, plays a key role in the ubiquitylation and degradation of G6PD, which is 238 an important anti-oxidant component.
239
The injury and loss of podocytes plays a critical role in the initiation and development of DKD, while 240 the mechanisms are not fully revealed [31] . Here, our results show that G6PD protein level in both 241 podocytes from diabetic patients and podocytes exposed to high glucose are significantly decreased, 242 which may explain the injury and loss of podocytes in DKD.
243
G6PD is the rate-limiting enzyme in the pentose phosphate pathway, which plays a critical role in cell 244 growth by providing NADPH for redox regulation [32, 33] . Cells with normal G6PD activity keep the 245 net ROS production at a reasonably low level. However, G6PD deficiency will cripple the antioxidant 246 defense, resulting in the build-up of oxidative damage. Previously, we and others showed that G6PD 247 deficiency led to increased accumulation of ROS in many cell types, which impaired the cellular 248 function and survival [18, 21] . In this study, we reported, for the first time, that high glucose-induced 249 G6PD deficiency in podocytes resulted in increased ROS accumulation and apoptosis, which could be 250 rescued by overexpressing G6PD. We previously demonstrated that non-diabetic G6PD deficient 251 mice had increased urinary albuminuria [22] and here in the same mouse model, we reported that 252 G6PD deficiency led to significant podocyte loss due to increased apoptosis. Since podocytes are 253 terminally differentiated epithelial cells, the loss of podocytes would eventually lead to the increased urinary albuminuria. The above results demonstrated that G6PD played vital roles in maintaining the 255 survival and function of podocyte.
256
Due to the decrease of G6PD induced by high glucose, NADPH and GSH levels were decreased, 257 which resulted in the depletion of glutathione stores and enhanced oxidative stress. Further support for 258 the role of G6PD in regulation of NADPH and GSH was that overexpression of G6PD conferred 259 protection on podocytes exposed to high glucose. There is accumulating evidence to support this 260 finding in other cell types. Mouse embryonic fibroblasts cells with increased G6PD level are more 261 resistant to the oxidant tert-butyl hydroperoxide than cells with low G6PD activity [34] . Our previous 262 studies have shown overexpressing G6PD prevents the high glucose-mediated ROS accumulation in 
In vivo ubiquitylation assay
To check the ubiquitylation status of G6PD, Flag-G6PD was immunoprecipitated from the cells 445 treated with proteasome inhibitor MG132. For Figure 7E and Figure 
750
A Overexpressing G6PD increased NADPH level in podocytes exposed to high glucose. Podocytes 
824
A The map of the 5 lysine sites for VHL mediated ubiquitylation on G6PD. HEK293T cells were 825 transfected with Flag-G6PD, His-Ub and HA-VHL plasmids, and then ubiquitylated G6PD were 826 immunoprecipitated with anti-Flag M2 beads. MS spectra analysis identified 5 Lys residues (K 97 , K 366 , 827 K 403 , K 407 and K 408 ) for VHL-mediated ubiquitylation in G6PD.
828
B K 366 and K 403 were the major sites for VHL-mediated ubiquitylation on G6PD. HEK293T cells were 829 transfected with Flag-tagged wild-type G6PD (WT) or its mutants bearing single Lys-to-Arg 830 substitutions at the above 5 potential ubiquitylation sites. Cell lysates were subjected to 831 immunoprecipitation (IP) with anti-Flag M2 beads. The precipitates were probed using His and Flag 832 antibodies.
833
C Mutants with both K 366 and K 403 sites (K 366+403R ) largely abolished the ubiquitylation of G6PD.
834
HEK293T cells were transfected with Flag-tagged wild-type G6PD (WT) or G6PD mutants bearing 835 single or two Lys-to-Arg substitutions at K 366 and K 403 sites. 
